OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase
Yuli Lin, Qian Cai, Yu Chen, et al.
Hepatology (2021) Vol. 75, Iss. 1, pp. 28-42
Closed Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21

Research progress of bone metastases: From disease recognition to clinical practice
Wenbo Yang, Qing Pan, Fuhua Huang, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 20

Alterations in histology of the aging salivary gland and correlation with the glandular inflammatory microenvironment
Ning Li, Yulin Ye, Yi‐Cheng Wu, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106571-106571
Open Access | Times Cited: 20

Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20

Heterogeneity of Cholangiocarcinoma Immune Biology
Francesca Vita, Irene Olaizola, Francesco Amato, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 846-846
Open Access | Times Cited: 18

Identification of cancer-associated fibroblasts subtypes in prostate cancer
Jiahua Pan, Zehua Ma, Бо Лю, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Hengsong Cao, Tian Huang, Mingrui Dai, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5369-5390
Open Access | Times Cited: 26

Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
Mario Alba, Brandon Ebright, Brittney Hua, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 14

Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
Qianqian Guo, Yi Zhou, Tianyuan Xie, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101043-101043
Open Access | Times Cited: 14

FAP expression in adipose tissue macrophages promotes obesity and metabolic inflammation
Yunyun Wu, Chao Wu, Tiancong Shi, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 51
Open Access | Times Cited: 13

Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer
Hao Zhong, Shiyue Zhou, Shuangshuang Yin, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5

Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1
Kejia Lv, Sizhe Yu, Yu Wang, et al.
Cellular Signalling (2024), pp. 111378-111378
Open Access | Times Cited: 4

Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis
Jing Li, Xueting Ren, Lin Cao, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

Heterogeneity of the tumor immune cell microenvironment revealed by single-cell sequencing in head and neck cancer
Chunhong Li, Jia Liao, Bo Chen, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104677-104677
Open Access

Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy
Linhui Zheng, Wenqi Cai, Ke Yuan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights
Kuan-Jung Chiu, Hung‐Yi Chiou, Chi-Han Huang, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 713-713
Open Access | Times Cited: 16

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, et al.
Translational Oncology (2022) Vol. 25, pp. 101514-101514
Open Access | Times Cited: 16

Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
Michele Montori, Chiara Scorzoni, Maria Eva Argenziano, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6498-6498
Open Access | Times Cited: 16

Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages
Takuto Nosaka, Y. Murata, Kazuto Takahashi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114592-114592
Open Access | Times Cited: 10

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in cancer
Lingfei Li, Mingyang Li, Qingge Jia
Pathology - Research and Practice (2023) Vol. 248, pp. 154711-154711
Closed Access | Times Cited: 10

DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer
Guoying Dong, Qin Wang, Mingxin Wen, et al.
Oncogene (2023) Vol. 42, Iss. 40, pp. 3000-3014
Closed Access | Times Cited: 10

Scroll to top